Folks, this is nothing new . . .

So not everyone’s happy about the new NCEP cholesterol guidelines.  Drug companies funding studies is absolutely nothing new.  In this case, the data is sound and peer-reviewed.  True, it’s not a completely ideal source of funds, but the money’s got to come from somewhere.